Clinical impact of mild carbohydrate intolerance in pregnancy: A study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus
American Journal of Obstetrics and GynecologyPublished 1 August 2001
Dorte M. Jensen, Peter Damm, Bente Sørensen, Lars Mølsted‐Pedersen, J.G. Westergaard, Joachim G. Klebe
Citations160
SJR quartileQ1
SJR score2.77
SNIP2.75
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
In a group of nondiabetic pregnant women with risk factors for gestational diabetes, there was a graded increase in the frequency of shoulder dystocia and other maternal-fetal complications with increasing glucose levels during an oral glucose tolerance test.
Abstract
In a group of nondiabetic pregnant women with risk factors for gestational diabetes, there was a graded increase in the frequency of shoulder dystocia and other maternal-fetal complications with increasing glucose levels during an oral glucose tolerance test.
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
Diabetes CareSummary and Recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus
1,914 Citations2007Boyd E. Metzger, Thomas A. Buchanan +11 more
American Journal of Obstetrics and GynecologyImpact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes
514 Citations1995Mathew Sermer, C. David Naylor +9 more
Increasing maternal carbohydrate intolerance in pregnant women without gestational diabetes is associated with a graded increase in adverse maternal-fetal outcomes, which is an independent predictor for various unfavorable outcomes.
DiabetesDiabetes Mellitus After GDM
333 Citations1991John B. O’Sullivan
There is broad general agreement on the predictive nature of gestational blood glucose levels, and the differences between WHO and National Diabetes Data Group criteria and the allowable modifications within each of the diagnostic standards all result in different incidence rates of diabetes.
American Journal of Obstetrics and GynecologyGestational diabetes and perinatal mortality rate
296 Citations1973John B. O’Sullivan, David Charles +2 more
Age was found to have a disproportionately adverse effect, enhanced slightly by obesity, on the pregnancies of gestational diabetic patients when compared with those of negative control patients.
Diabetes CareGestational Diabetes: Infant and Maternal Complications of Pregnancy in Relation to Third-Trimester Glucose Tolerance in the Pima Indians
281 Citations1980David J. Pettitt, William C. Knowler +2 more
A modified oral glucose tolerance test was done during the third trimester in 811 pregnancies in Pima Indian women over a 13-yr period, and maternal and fetal complications were documented, and the third-trimester glucose concentration was highly predictive of the subsequent incidence of diabetes.
American Journal of Obstetrics and GynecologyToward universal criteria for gestational diabetes: The 75-gram glucose tolerance test in pregnancy
217 Citations1995David A. Sacks, Jeffrey S. Greenspoon +4 more
In the absence of a meaningful threshold relationship between glucose tolerance test values and clinical outcome, criteria defining gestational diabetes will probably be established by consensus.
American Journal of Obstetrics and GynecologyPredictive factors for the development of diabetes in women with previous gestational diabetes mellitus
196 Citations1992Peter Damm, Claus Kühl +2 more
European Journal of EndocrinologyGLUCOSE METABOLISM DURING AND AFTER PREGNANCY IN NORMAL AND GESTATIONAL DIABETIC WOMEN
152 Citations1975Christiane Kühl
The results indicate that in pregnancy a diminished "peripheral sensitivity" to endogenous insulin apparently develops.
DiabetesInfluence of Pregnancy on the 75-g OGTT: A Prospective Multicenter Study
117 Citations1991Thomas Lind, Peter R Phillips
The responses to a 75-g oral glucose tolerance test (OGTT) in 1009 pregnant women from throughout Europe raised the question of whether the apparent longer-term consequences such as coronary artery disease and hypertension are not in some measure due to these factors rather than carbohydrate intolerance alone.
American Journal of Obstetrics and GynecologySequelae of unrecognized gestational diabetes
115 Citations1998Kristina M. Adams Waldorf, Hongzhe Li +3 more
This study suggests that unrecognized gestational diabetes increases risks of large for gestational age infants, macrosomia, shoulder dystocia, and birth trauma independent of maternal obesity and other confounding variables.
Early Human DevelopmentNormal fetal growth evaluated by longitudinal ultrasound examinations
88 Citations1990Torben Larsen, Sten Petersen +2 more
Fetal weight estimation was evaluated using the equations of Warsof, Shepard and Hadlock in 192 patients, less than 3 days before delivery, and significant higher mean weight was found, especially before 31 weeks of gestational age.
PubMedEffect of maternal metabolism on fetal growth and body composition.
81 Citations1998Patrick M. Catalano, Alicia Thomas +2 more
Assessment of fetal/neonatal body composition may improve understanding of the effect of differential factors on fetal growth and the relationship between maternal weight gain and birth weight in women with normal glucose tolerance and gestational diabetes mellitus.
Diabetes CarePregnancy Outcomes in Women Without Gestational Diabetes Mellitus Related to the Maternal Glucose Level: Is there a continuum of risk?
78 Citations1995Robert G. Moses, Dennis Calvert
In normal women there is a continuum of risk related to the maternal glucose level 2 h after a glucose tolerance test for the probability of having an assisted delivery and the likelihood of the baby being admitted to an SCN.
International Journal of ObesityTen-year trends in overweight and obesity among Danish men and women aged 30–60 years
74 Citations2000Berit L. Heitmann
There is a considerable increase in the proportion of adult Danes with a BMI ≥30 kg/m2 corresponding to an estimated extra 75,000 severely overweight 30–60 y olds in the period, in line with the general international increase.
Journal of Perinatal MedicineHyperinsulinism, neonatal obesity and placental immaturity in infants born to women with one abnormal glucose tolerance test value
62 Citations1998Ute Schäfer‐Graf, J. Dupak +5 more
Pregnancies with glucose intolerance below the thresholds for diagnosis of GDM have an increased risk for fetal obesity, hyperinsulinism, postpartum hypoglycemia and placental immaturity, and these findings indicate the continuum of risk for Fetal morbidity associated with increasing maternal glucose intolerance in pregnancy.
European Journal of EndocrinologyPRACTICAL SCREENING FOR DIABETES MELLITUS IN PREGNANT WOMEN
52 Citations1974Eigil Guttorm
PubMed[Perinatal growth. A practical perinatal growth curve].
19 Citations1989Gorm Greisen, Kim F. Michaelsen
A linear perinatal growth curve, covering the period from 28 weeks gestation to 18 weeks after term birth, is presented and may be used for classification of birth weight in relation to gestational age and at the same time for monitoring of postnatal growth.
PubMedA screening procedure for diabetes in pregnancy.
18 Citations1985Henrik B. Mortensen, Lars Mølsted‐Pedersen +2 more
It was established that a fasting blood glucose concentration of 4.1 mmol/l was the ideal cut-off point for referring potential diabetics to an oral glucose tolerance test (OGTT) and the screening OGTT procedure is easy to administer and acceptable for the pregnant woman.
European Journal of EndocrinologyEFFECT OF WITHDRAWAL OF GROWTH HORMONE ADMINISTRATION ON LONGITUDINAL BONE GROWTH IN THE HYPOPHYSECTOMIZED RAT
15 Citations1974K.‐G. Thorngren, Lennart Hansson
Longitudinal bone growth, studied in the proximal tibia, was reactivated and continued at an accelerating rate during the period of hormone administration and for a further 5 days after its withdrawal, but then ceased.